Sources: US News
Pfizer and its German partner BioNTech begin a clinical trial to test the safety and immune response of their Omicron-specific COVID-19 vaccine for adults under the age of 55 years. 2022-01-25
Pfizer CEO Albert Bourla says that the company will develop a COVID-19 vaccine to target the Omicron variant by March. 2022-01-10
Bahrain authorizes the emergency use of Pfizer's anti-viral oral drug Paxlovid for adults over the age of 18 years. 2022-01-1
Israeli Prime Minister Naftali Bennett announces that a deal has been reached with Pfizer CEO Albert Bourla, which would see a new shipment of vaccines delivered on August 1. 2021-07-11
South Africa signs a deal with Pfizer to supply 20 million doses of the Pfizer–BioNTech vaccine. The first shipment is expected to arrive in late April. 2021-04-6
The Food and Drug Administration approves the Pfizer–BioNTech vaccine for emergency use in the country. 2021-01-14
Prime Minister Benjamin Netanyahu becomes the first Israeli to get a second dose of Pfizer's tozinameran vaccine as the country begins administering second doses of the vaccine to the public. 2021-01-9
Spain receives its first shipment of the Pfizer-BioNTech vaccine tozinameran in Guadalajara, a day before the country begins its vaccination programme. 2020-12-26
Iraq signs a preliminary deal to receive 1.5 million doses of the Pfizer-BioNTech vaccine Tozinameran. Ministry of Health spokesman Seif al-Badr says troops and the elderly will be prioritized for vaccinations. 2020-12-22
The European Medicines Agency announces that they will launch a review for vaccines developed by Pfizer and BioNTech. 2020-10-6